Month: November 2018

Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States

Recently co-authored a retrospective study of nearly 16,000 patients with diabetic macular edema (DME), a common cause of visual impairment: At 1 year, despite treatment, real-world DME patients have meaningfully worse visual outcomes compared to patients in randomized controlled trials, and those with well-preserved baseline […]

Stargardt macular dystrophy and evolving therapies

Just published this review on Stargardt Macular Dystrophy with colleagues from Bascom Palmer… Stargardt macular dystrophy and evolving therapies (2018). Stargardt macular dystrophy and evolving therapies. Expert Opinion on Biological Therapy: Vol. 18, No. 10, pp. 1049-1059. Return to main website.